Press Releases Rebus Holdings, Inc.

Equities

RBSH

US75619J1034

Market Closed - OTC Markets Other stock markets 10:59:36 2024-06-13 EDT			5-day change	1st Jan Change
0.0001 ^USD	+9,900.00%		0.00%	-98.04%

2023	Rebus Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
2023	Rebus Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

REBUS HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	23-03-31	AQ
NOTE 2 - MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN	22-11-21	AQ
REBUS HOLDINGS, INC. : Changes in Registrant's Certifying Accountant (form 8-K)	22-11-16	AQ
REBUS HOLDINGS, INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	22-10-13	AQ
Rebus : Quarterly Report for Quarter Ending June 30, 2022 (Form 10-Q)	22-08-12	PU
NOTE 2 - MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN	22-08-12	AQ
NOTE 2 - MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN	22-05-13	AQ
REBUS HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	22-03-31	AQ
NOTE 2 - MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN	21-11-12	AQ
Inspyr Therapeutics : Material Event - Form 8-K/A	21-10-12	PU
INSPYR THERAPEUTICS : Form 8-K	21-10-12	PU
INSPYR THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	21-10-12	AQ
Inspyr Therapeutics : AGREEMENT AND PLAN OF MERGER (Form 8-K)	21-10-05	PU
INSPYR THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	21-10-05	AQ
Inspyr Therapeutics : NOTE 2 - MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN	21-08-16	AQ
Inspyr Therapeutics : SENIOR CONVERTIBLE DEBENTURE DUE JUNE 18, 2022 (Form 8-K)	21-06-21	PU
INSPYR THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	21-06-21	AQ
Inspyr Therapeutics : NOTE 2 - MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN	21-05-17	AQ
INSPYR THERAPEUTICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	21-03-31	AQ
INSPYR THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)	21-01-12	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Rebus Holdings, Inc.

Equities

RBSH

US75619J1034

Press Releases

Filters